Investors
Orasis is funded by a diverse group of sophisticated investors with proven track records in the healthcare space.
In October 2024, Orasis announced a Series D financing co-led by Arboretum Ventures and Johnson & Johnson Innovation – JJDC, Inc.
Arboretum Ventures
Arboretum Ventures, LLC (“Arboretum”) is a venture capital firm, founded in 2002, specializing in the healthcare sector. The firm has raised $1 billion in capital across its funds with the most recent Fund VI closing in 2023 at $268 million. Arboretum focuses on capital-efficient investment opportunities in medical devices, life science tools & diagnostics, tech-enabled care delivery, and pharma adjacencies. Arboretum’s guiding vision is to identify transformative healthcare companies developing novel solutions to significant healthcare issues that simultaneously reduce cost and improve outcomes.
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC, Inc. (JJDC) is the strategic venture capital arm of Johnson & Johnson. JJDC pursues opportunities to solve critical healthcare needs. JJDCs’ portfolio companies benefit from the full global capabilities of Johnson & Johnson as we collaborate to drive innovation.
Catalio Capital Management
Catalio Capital Management, LP, is a multi-strategy healthcare and life sciences investment firm focusing on breakthrough companies developing the next generation of drugs, devices, diagnostics, and data-driven insights. Catalio’s exclusive network includes over 44 world-renowned scientists with extensive academic and scientific achievements who have each started well-established companies based on their research. Catalio has offices in New York and London.
Visionary Ventures
Visionary Ventures is a later-stage venture fund focused on investing in drugs and devices for the eye. Visionary employs a unique approach to venture investing by partnering with over 40 key opinion leader ophthalmologists, as well as other sophisticated investors and industry professionals.
Bluestem Capital
With more than 95 years of collective experience, Bluestem Capital is a private equity and venture capital firm with 25 portfolio companies. Healthcare is a leading investment area for the firm, with continued emphasis on eyecare innovation.
SBI (Japan) Innovation Ventures
SBI (Japan) Innovation Fund is a biopharma focused venture capital fund that invests in Israeli venture-backed biopharma companies with cutting-edge science.
Sequoia Capital
Sequoia Capital is a global venture capital firm focusing on the technology and healthcare industry.
LifeSci Venture Partners
LifeSci Venture Partners is the venture investing arm of LifeSci Partners, a unique life sciences and healthcare consultancy.
Maverick Ventures Israel
Maverick Ventures Israel invests in Israeli companies with cutting edge innovations.